DP VIII Associates, L.P.

DP VIII Associates, L.P. discloses dealings in 4 companies, chiefly Bionano Genomics, Inc., Dicerna Pharmaceuticals Inc and Ocera Therapeutics, Inc. Between 8 March 2016 and 23 August 2018, the trades on record add up to 6 filings.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The latest filing, published on 27 August 2018, reports a transaction in Bionano Genomics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.